The Reading Room Podcast: Emerging Trends with Theranostics in Prostate Cancer, Part 1

In the first of a two-part podcast episode, Jeremie Calais, M.D., and Robert Flavell, M.D., discuss recent advances with PSMA-targeted radiotracers in the treatment of metastatic castration-resistant prostate cancer (PCa), and the role of imaging criteria in monitoring patients treated with PSMA-targeted radionuclide therapy.